person
as of 2026-07-01Merete Nordentoft, MD, PhD, MPH
Merete Nordentoft, ProfessorMerete Nordentoft, professor
ORCID 0000-0003-4895-7023
at a glance
Roles: Principal Investigator, Study Chair, Study Director, Author, Investigator+Author
KOL signal score 8
1 publications · 1 high-value
Synthesized from structured facts only — each point cited above.
Profile
Affiliation
Psychiatric Center Copenhagen
Roles
Principal Investigator, Study Chair, Study Director, Author, Investigator+Author
KOL signal
8
Publications
1 (1 high-value)
Trial investigator
yes
Trials led
8
Effects of Neurocognitive and Social Cognitive Remediation in Patients at Ultra-High Risk of Psychosis
NCT02098408—Completed
Specialized Addiction Treatment Versus Treatment as Usual for Young Patients With Cannabis Abuse and Psychosis
NCT00484302—Completed
Specialized Addiction Treatment Versus Treatment as Usual for Young Patients With Cannabis Abuse and Psychosis
NCT00484302—Completed
Extended Specialized Assertive Intervention for First Episode Psychosis
NCT00914238—Completed
CHALLENGE. A Randomised Clinical Trial Examining Virtual Reality Therapy
NCT04661163—Completed
CHANGE -it is About Life
NCT01585493Phase 3Completed
Neurocognitive Training Integrated in OPUS Treatment Versus OPUS Treatment-as-usual
NCT00472862Phase 3Completed
Improving Work Outcome for People With Severe Mental Illness
NCT01722344—Completed
Publications & congress
1
Treatment effect modifiers of virtual reality-based versus standard cognitive behavioral therapy for paranoia in schizophrenia spectrum disorders: an exploratory moderator analysis of clinical and demographic characteristics in the FaceYourFears trial.
Psychological medicine · 2026 · high-value
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
PRINCIPAL_INVESTIGATOR